Definitive Contract 75D30122C15411
Award Date
9/13/22
Potential Completion Date
9/12/26
Potential Value
$735K
Federal Agency
CDC Pittsburgh
Awardee
University Of Texas At Austin
Ultimate Awardee
University Of Texas System
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Austin, TX 78712, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the University of Texas at Austin, a non-profit public research university, for a contract valued at $401,203.00. The contract is for the development of a "Modeling Toolkit to Evaluate Multifaceted Control Strategies for Seasonal and Pandemic Influenza." This project will utilize modeling and forecasting tools to improve the U.S. response to...
This federal contract award, valued at $250,000.00, was granted by the Centers for Disease Control and Prevention (CDC) to the University of Texas at Austin (UT Austin). The contract is for the "STRENGTHENING PERTUSSIS SURVEILLANCE AND DIAGNOSTICS BY IMPROVEMENTS IN ANTIGEN PRODUCTION", with a period of performance ending on September 29, 2026. The contract is a definitive contract with a cost-no-fee pricing type, and there is no set-aside designation. As a major research university,...
The Centers for Disease Control and Prevention (CDC) awarded a $638,884 Firm Fixed Price Definitive Contract to the University of Texas at Austin to provide SUPPORT SERVICES. The University of Texas at Austin will serve as the prime contractor and will subcontract with the University of Georgia Research Foundation, Inc. doing business as UGA Research Foundation for INFECTIOUS DISEASE MODELING AND ANALYTIC services in support of the CDC's mission. The contract has a period of performance from...
The University of Texas Health Science Center at Houston (UTHealth) was awarded a $345,790.34 firm fixed price contract from the Centers for Disease Control and Prevention (CDC) in Pittsburgh for the "LAMP STUDY HOUSTON" project. The contract has an ultimate completion date of May 31, 2024. UTHealth has extensive experience conducting biomedical and public health research under federal contracts and grants, frequently collaborating with other academic institutions and government...
This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the University of Texas Health Science Center at Houston (UTHealth), a state-controlled institution of higher learning, for an Elastomeric Respirator Study. The firm fixed-price contract has a potential value of $833,009.00 and a completion date of August 31, 2023. The contract is not set aside. As a prime contractor, UTHealth has provided research services,...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Texas A&M University, a public land-grant research university, for a project titled "TX SEA GRANT COVID REPORTS". The $10,426.00 firm-fixed-price purchase order has an ultimate completion date of April 4, 2025. This contract is not set aside and is part of the Texas A&M University System's extensive portfolio of federal contract and grant awards. The university has demonstrated...
This federal contract award, valued at $699,713.00, was issued by the Centers for Disease Control and Prevention (CDC) to Texas A&M AgriLife Research, a component of the Texas A&M University System. The contract, which does not have a set-aside designation, is for work under the CDC's 2020 Broad Agency Announcement (BAA) Topic 2.1. The contract is a definitive, firm fixed-price agreement with a performance period ending on December 31, 2023. Texas A&M AgriLife Research is a state...
This is a $710,772.20 cost-no-fee definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to the University of Texas Medical Branch at Galveston (UTMB) on June 1, 2021. The contract is for FY 21 BAA Topic 8 and has a completion date of October 30, 2022. UTMB is a medical institution that provides a wide range of services to the federal government, including biomedical research, clinical trials, medical training, public health...
The University of Texas Medical Branch at Galveston (UTMB) was awarded a $390,168 Definitive Contract by the Centers for Disease Control and Prevention (CDC) Pittsburgh to conduct work related to Funding Announcement Number FY23 BAA - TOPIC 24. As the prime contractor, UTMB will perform this work in Galveston, Texas from September 1, 2023 through August 31, 2024. The contract pricing type is cost no fee, indicating UTMB will be reimbursed for allowable costs incurred with no potential for fee or...
This is a $4,591,813.00 federal contract awarded by the Department of the Army to the University of Texas at Austin (UT Austin) on April 5, 2024. The contract has a definitive contract type and cost-no-fee pricing structure, with an ultimate completion date of April 4, 2027. The contract was awarded under a Broad Agency Announcement (BAA) issued by the Army Research Laboratory (ARL) to support its foundational research mission across basic and applied research activities. The BAA sought...